HIV disease: a review for the family physician. Part II. Secondary infections, malignancy and experimental therapy.
The first part of this two-part article included recommendations for the initial evaluation of patients suspected of having HIV infection, the Centers for Disease Control's classification scheme for HIV disease and current recommendations for the use of zidovudine. In this second part, secondary infections and malignancy are reviewed, and various experimental therapies are briefly discussed.
Brooke
G L
GL
St. Mary Hospital, Hoboken, New Jersey.
Safran
G F
GF
Perlmutter
B L
BL
Perez
J A
JA
Zatlin
G S
GS
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications* / Q000628:therapy; D002177:Candidiasis / Q000150:complications; D003453:Cryptococcosis / Q000150:complications; D003586:Cytomegalovirus Infections / Q000150:complications; D006801:Humans; D008223:Lymphoma / Q000209:etiology; D009165:Mycobacterium Infections, Nontuberculous / Q000150:complications; D009894:Opportunistic Infections / Q000150:complications*; D011020:Pneumonia, Pneumocystis / Q000150:complications; D012514:Sarcoma, Kaposi / Q000209:etiology; D014123:Toxoplasmosis / Q000150:complications; D014376:Tuberculosis / Q000150:complications